ArticleThe pharmacogenomics journal2024
Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
Adriana Vázquez-Medina et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it